OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron
Masayuki Amano, Sachiko Otsu, Yukari Uemura, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Masayuki Amano, Sachiko Otsu, Yukari Uemura, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity
Sabryna Nantel, Salma Sheikh‐Mohamed, Gary Chao, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 201-210
Open Access | Times Cited: 9
Sabryna Nantel, Salma Sheikh‐Mohamed, Gary Chao, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 201-210
Open Access | Times Cited: 9
Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
Inga Tometten, Tobias Brandt, Maike Schlotz, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Inga Tometten, Tobias Brandt, Maike Schlotz, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Rohan Ameratunga, A. M. Jordan, Klaus Lehnert, et al.
Antiviral Research (2024) Vol. 227, pp. 105894-105894
Closed Access | Times Cited: 2
Rohan Ameratunga, A. M. Jordan, Klaus Lehnert, et al.
Antiviral Research (2024) Vol. 227, pp. 105894-105894
Closed Access | Times Cited: 2
Follow-up of Immune Response in Patients with Common Variable Immunodeficiency following SARS-CoV-2 Vaccination
Juan Francisco Gutiérrez‐Bautista, Irene Díaz-Alberola, María Tarriño, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 3, pp. 253-262
Closed Access | Times Cited: 2
Juan Francisco Gutiérrez‐Bautista, Irene Díaz-Alberola, María Tarriño, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 3, pp. 253-262
Closed Access | Times Cited: 2
Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4–5 vaccine and practical application of dried blood spots
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126029-126029
Open Access | Times Cited: 1
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126029-126029
Open Access | Times Cited: 1
COVID-19 mRNA booster vaccination induces robust antibody responses but few adverse events among SARS-CoV-2 naïve nursing home residents
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spots
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV
Giulia Matusali, Alessandra Vergori, Eleonora Cimini, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access
Giulia Matusali, Alessandra Vergori, Eleonora Cimini, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access
Comparative Analysis of Adverse Event Rates and Severity Following COVID-19 mRNA Vaccinations Among SARS-CoV-2 Naïve Nursing Home Residents and Staff
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Research Square (Research Square) (2024)
Open Access
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, et al.
Research Square (Research Square) (2024)
Open Access
Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination
Masayuki Amano, Yasuko Ichikawa, Shota Matsumoto, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106179-106179
Closed Access
Masayuki Amano, Yasuko Ichikawa, Shota Matsumoto, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106179-106179
Closed Access
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case
Takeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
EBioMedicine (2024) Vol. 110, pp. 105439-105439
Closed Access
Takeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
EBioMedicine (2024) Vol. 110, pp. 105439-105439
Closed Access
